The round, which brought total funding to $40M, was led by Square Peg Capital.
The company intends to use the funds to grow technology and go-to-market team.
Led by co-founder and CEO Elad Walach, Aidoc is an AI healthcare company whose FDA-cleared and CE-marked solutions reduce turnaround time and increase quality and efficiency by flagging acute anomalies in real-time.
Its healthcare-grade deep learning algorithms benefit from large quantities of data to make their solutions comprehensive in the field, and enable them to provide diagnostic aid to the broadest set of pathologies.
Aidoc is currently deployed at over 100 medical centers and has just hit the 1 million mark for total patients reviewed.
In the next months, the company will be releasing its oncology line of products as well as the extension of its current suite for time-sensitive conditions to X-ray.
FinSMEs
17/04/2019